San Diego, CA, United States of America

Bruno Tse

USPTO Granted Patents = 11 


Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Edison, NJ (US) (1999 - 2000)
  • Philadelphia, PA (US) (2006)
  • Vista, CA (US) (2009)
  • San Diego, CA (US) (2005 - 2013)
  • San Francisco, CA (US) (2017)

Company Filing History:


Years Active: 1999-2017

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Contributions of Bruno Tse

Introduction

Bruno Tse is a prominent inventor based in San Diego, California, known for his significant contributions to the field of biotechnology. With a total of 11 patents to his name, Tse has made remarkable advancements in the modulation of immune responses, particularly in relation to T-17 cells.

Latest Patents

One of Tse's latest patents focuses on modulators of retinoid-related orphan receptor gamma (RORγ). This invention outlines methods for modulating RORγ activity, which can either inhibit or stimulate its function. The modulation of RORγ has numerous effects, including the inhibition of T-17 cell function and activity, which is beneficial for treating inflammation and autoimmune disorders. Conversely, stimulation of RORγ enhances T-17 cell function, which can be advantageous for immune-enhancing compositions, such as vaccines.

Career Highlights

Throughout his career, Bruno Tse has worked with notable companies in the pharmaceutical industry, including Merck & Company, Inc. and Orphagen Pharmaceuticals. His experience in these organizations has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Tse has collaborated with esteemed colleagues, including James M Balkovec and Scott Thacher, contributing to a dynamic exchange of ideas and expertise in the field of biotechnology.

Conclusion

Bruno Tse's work exemplifies the impact of innovation in biotechnology, particularly in the modulation of immune responses. His patents and collaborations continue to pave the way for advancements in treatments for inflammation and autoimmune disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…